Market closed
Apyx Medical/$APYX
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Apyx Medical
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.
Ticker
$APYX
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
252
Website
Apyx Medical Metrics
BasicAdvanced
$53M
Market cap
-
P/E ratio
-$0.82
EPS
1.21
Beta
-
Dividend rate
Price and volume
Market cap
$53M
Beta
1.21
52-week high
$3.26
52-week low
$0.97
Average daily volume
53K
Financial strength
Current ratio
5.459
Quick ratio
4.296
Long term debt to equity
343.815
Total debt to equity
346.941
Interest coverage (TTM)
-3.97%
Management effectiveness
Return on assets (TTM)
-22.18%
Return on equity (TTM)
-127.39%
Valuation
Price to revenue (TTM)
1.013
Price to book
4.46
Price to tangible book (TTM)
4.46
Price to free cash flow (TTM)
-2.75
Growth
Revenue change (TTM)
-3.49%
Earnings per share change (TTM)
89.17%
3-year revenue growth (CAGR)
4.00%
3-year earnings per share growth (CAGR)
24.58%
What the Analysts think about Apyx Medical
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Apyx Medical stock.
Apyx Medical Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Apyx Medical Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Apyx Medical News
AllArticlesVideos
Apyx Medical Corporation to Attend 15th Annual Craig-Hallum Alpha Select Conference
GlobeNewsWire·1 week ago
Apyx Medical Corporation (APYX) Q3 2024 Earnings Call Transcript
Seeking Alpha·2 weeks ago
Apyx Medical Corporation Announces $7,000,000 Million Registered Direct Offering
GlobeNewsWire·2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Apyx Medical stock?
Apyx Medical (APYX) has a market cap of $53M as of November 23, 2024.
What is the P/E ratio for Apyx Medical stock?
The price to earnings (P/E) ratio for Apyx Medical (APYX) stock is 0 as of November 23, 2024.
Does Apyx Medical stock pay dividends?
No, Apyx Medical (APYX) stock does not pay dividends to its shareholders as of November 23, 2024.
When is the next Apyx Medical dividend payment date?
Apyx Medical (APYX) stock does not pay dividends to its shareholders.
What is the beta indicator for Apyx Medical?
Apyx Medical (APYX) has a beta rating of 1.21. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.